Monitoring the safety of UPLIZNA in pregnant women with NMOSD
Official title: An Observational Pregnancy Safety Study in Women With Neuromyelitis Optica Spectrum Disorder (NMOSD) Exposed to UPLIZNA® (Inebilizumab-cdon) During Pregnancy
Run by Amgen · NCT05909761 · Data updated 2026-11-12
This study is trying to see how safe the medication UPLIZNA is for pregnant women with Neuromyelitis Optica Spectrum Disorder (NMOSD) by tracking their pregnancies and outcomes over the next 10 years.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 15 Years and up |
| Sex | Women only |
| Enrollment | 60 (estimated) |
| Sponsor | Amgen Industry-sponsored |
| Locations | 1 site (Aurora, Colorado) |
| Status | Recruiting |
| Started | January 15, 2027 |
| Main results expected | October 31, 2032 |
| Study ends | October 31, 2032 |
| Registry record updated | October 29, 2026 |
| Trial ID | NCT05909761 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are women of reproductive potential with a confirmed or suspected diagnosis of NMOSD who have been exposed to UPLIZNA during pregnancy.
✕Probably not a fit
Patients who are not pregnant or have not been exposed to UPLIZNA during pregnancy or within the preceding six months may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to monitor female participants diagnosed with Neuromyelitis Optica Spectrum Disorder (NMOSD) who have been exposed to UPLIZNA during pregnancy or within six months prior to conception. Participants will voluntarily report their pregnancies, and the study will collect data on pregnancy outcomes, potential confounding factors, and other relevant information over a minimum duration of 10 years. The schedule of office visits and treatment regimens will be determined by the participants' healthcare providers.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into the safety of UPLIZNA during pregnancy, potentially guiding treatment decisions for women with NMOSD.
How similar studies have gone: While there may be limited data on similar studies, the observational nature of this study is crucial for understanding the implications of UPLIZNA exposure during pregnancy, making it a novel approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Provide informed consent * Are a female of reproductive potential with a confirmed or suspected diagnosis of NMOSD * Have been exposed to UPLIZNA during pregnancy as defined by receipt of any dose during pregnancy or within 6 months preceding conception Note: Other Protocol Defined Inclusion/Exclusion Criteria Apply
Where it's running
-
University of Colorado Denver
Aurora, Colorado, United States Recruiting
Study contacts
- Study coordinator: Amgen Call Center
- Email: medinfo@amgen.com
- Phone: 866-572-6436
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Prenatal education to reduce environmental exposures during pregnancy
Aimed at pregnant people, this program tests whether a classroom-style education can help reduce exposure to harmful pollutants from seafood and nearby pollution sources.
-
Interprofessional Training to Improve Care for Peri-Delivery Patients with Substance Use Disorder
This program tests INSPIRE, a set of online and in-person trainings for healthcare teams to reduce stigma and improve care for people with substance use disorder around labor, delivery, and postpartum at the University of Utah.
-
Lower-extremity blood pressure monitoring during cesarean under spinal anesthesia
This study tests whether noninvasive blood pressure monitoring from the toe is better than the arm at predicting neonatal outcomes during cesarean delivery with spinal anesthesia.
-
Care4mommies: a compassion-based approach to support moms-to-be
A compassion-based program with pregnancy-specific content is being tested to see if it helps pregnant people build self-compassion and strengthen the bond with their baby.
-
Eating more eggs during pregnancy to support fetal brain development
This test will see if pregnant women who eat 10–14 eggs per week have better fetal brain development than those who follow a general healthy prenatal diet.
-
See if extra prenatal breastfeeding education helps moms in Inland Empire breastfeed exclusively
This study tests whether supplemental breastfeeding education during pregnancy increases exclusive breastfeeding at 6 weeks after birth for first-time moms or those who didn’t breastfeed long in the past.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.